CN110585137B - Preparation method of solid dispersion of magnolia officinalis alcohol extract - Google Patents

Preparation method of solid dispersion of magnolia officinalis alcohol extract Download PDF

Info

Publication number
CN110585137B
CN110585137B CN201910943398.5A CN201910943398A CN110585137B CN 110585137 B CN110585137 B CN 110585137B CN 201910943398 A CN201910943398 A CN 201910943398A CN 110585137 B CN110585137 B CN 110585137B
Authority
CN
China
Prior art keywords
magnolia officinalis
alcohol extract
carrier
ethanol
ethanol solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910943398.5A
Other languages
Chinese (zh)
Other versions
CN110585137A (en
Inventor
傅超美
刘芳
王潇
胡慧玲
章津铭
高飞
何单
张晨
赵明
廖倩
包懿文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu University of Traditional Chinese Medicine
Original Assignee
Chengdu University of Traditional Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu University of Traditional Chinese Medicine filed Critical Chengdu University of Traditional Chinese Medicine
Priority to CN201910943398.5A priority Critical patent/CN110585137B/en
Publication of CN110585137A publication Critical patent/CN110585137A/en
Application granted granted Critical
Publication of CN110585137B publication Critical patent/CN110585137B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a preparation method of solid dispersion of magnolia officinalis alcohol extract, which comprises the following steps: dissolving Magnolia officinalis ethanol extract lyophilized powder and carrier in ethanol solution, rotary evaporating to remove ethanol solution, drying, and pulverizing; the carrier consists of polyethylene glycol and poloxamer. The preparation method of the solid dispersion of the magnolia officinalis alcohol extract can prepare the solid dispersion of the magnolia officinalis alcohol extract with extremely high dissolution rate, is favorable for improving the total dissolution rate of magnolol and honokiol which are main effective ingredients of magnolia officinalis, improves the water solubility of the magnolia officinalis, improves the utilization rate of the magnolia officinalis, is convenient for further refining related preparations of the magnolia officinalis, and expands the clinical application.

Description

Preparation method of solid dispersion of magnolia officinalis alcohol extract
Technical Field
The invention relates to a preparation method of solid dispersion of magnolia officinalis alcohol extract.
Background
The cortex Magnolia officinalis is dry bark, root bark and branch bark of Magnolia officinalis of Magnoliaceae, Magnolia officinalis of Rhd. Hou Po is bitter and pungent in flavor and warm in nature. It enters spleen, stomach, lung and large intestine meridians. It can dry dampness, resolve phlegm, descend qi and remove fullness. Can be used for treating damp stagnation, abdominal distention, vomiting, diarrhea, food stagnation, qi stagnation, abdominal distention, constipation, phlegm retention, asthma, and cough. The main active ingredients in the magnolia officinalis, such as magnolol, honokiol and the like, are difficult to dissolve in water, the oral bioavailability is still low, the development of related product preparations is limited, and the clinical application is influenced. At present, the dissolution rate of the traditional Chinese medicine is improved from monomer components, and the characteristic of the overall action of multiple components of the traditional Chinese medicine is ignored.
Disclosure of Invention
In order to solve the problems, the invention provides a preparation method of solid dispersion of magnolia officinalis alcohol extract.
The invention provides a preparation method of solid dispersion of magnolia officinalis alcohol extract, which comprises the following steps:
dissolving Magnolia officinalis ethanol extract lyophilized powder and carrier in ethanol solution, rotary evaporating to remove ethanol solution, drying, and pulverizing;
the carrier consists of polyethylene glycol and poloxamer.
Further, the polyethylene glycol is polyethylene glycol 6000; the poloxamer is poloxamer 188.
Further, the mass ratio of the magnolia officinalis alcohol extract freeze-dried powder to the carrier is 1: 3-1: 9; the mass ratio of the polyethylene glycol to the poloxamer in the carrier is 1: 3-3: 1.
Further, the mass ratio of the magnolia alcohol extract freeze-dried powder to the carrier is 1: 5.4; the mass ratio of the polyethylene glycol to the poloxamer in the carrier is 0.9: 1.
Further, the ethanol solution is 80-95% ethanol solution; and/or the volume of the ethanol solution is 8-12 times (v/w) of the total mass of the magnolia officinalis alcohol extract freeze-dried powder and the carrier; preferably, the ethanol solution is 90% ethanol solution; and/or the volume of the ethanol solution is 10 times (v/w) of the total mass of the magnolia officinalis alcohol extract freeze-dried powder and the carrier.
Further, stirring the mixture when the mixture is dissolved in the ethanol solution, wherein the stirring time is 60-120 min; preferably, the stirring time is 115 min.
Further, the rotary evaporation condition is 70 ℃ water bath heating; and/or the drying is drying for 24 hours in a vacuum drying oven at 45 ℃; and/or, sieving the crushed materials by a 40-mesh sieve.
Further, the preparation method of the magnolia alcohol extract freeze-dried powder comprises the following steps:
taking mangnolia officinalis decoction pieces, crushing, carrying out hot reflux extraction on the mangnolia officinalis decoction pieces for 1-3 times by using 70-80% ethanol, filtering, combining filtrates, concentrating under reduced pressure, freeze-drying, and crushing to obtain the mangnolia officinalis decoction pieces; adding 6-10 times (v/w) of ethanol into the reflux extraction every time; the reflux extraction is carried out for 1-3 h each time.
Further, the preparation method of the magnolia alcohol extract freeze-dried powder comprises the following steps:
pulverizing cortex Magnolia officinalis decoction pieces, extracting with 70% ethanol under reflux for 2 times, filtering, mixing filtrates, concentrating under reduced pressure, freeze drying, and pulverizing; adding 8 times (v/w) of ethanol into the reflux extraction every time; the reflux extraction is carried out for 1.5h each time.
Further, the concentration under reduced pressure is carried out at 50 ℃ to recover the solvent until no alcohol smell exists.
In the invention, v/w is a volume-to-mass ratio and has a unit of mL/g.
The preparation method of the solid dispersion of the magnolia officinalis alcohol extract can prepare the solid dispersion of the magnolia officinalis alcohol extract with extremely high dissolution rate, is favorable for improving the total dissolution rate of magnolol and honokiol which are main effective ingredients of magnolia officinalis, improves the water solubility of the magnolia officinalis, improves the utilization rate of the magnolia officinalis, is convenient for further refining related preparations of the magnolia officinalis, and expands the clinical application.
Obviously, many modifications, substitutions, and variations are possible in light of the above teachings of the invention, without departing from the basic technical spirit of the invention, as defined by the following claims.
The present invention will be described in further detail with reference to the following examples. This should not be understood as limiting the scope of the above-described subject matter of the present invention to the following examples. All the technologies realized based on the above contents of the present invention belong to the scope of the present invention.
Drawings
FIG. 1 shows the dissolution rates of solid dispersion of Magnolia officinalis alcohol extract prepared by different preparation methods.
FIG. 2 shows the dissolution rate of solid dispersion of Magnolia officinalis alcohol extract prepared with different carrier types.
FIG. 3 shows the dissolution rates of solid dispersion of Magnolia officinalis alcohol extract in different dissolution media.
Detailed Description
The raw materials and equipment used in the embodiment of the present invention are known products and obtained by purchasing commercially available products. Wherein the decoction pieces of cortex Magnolia officinalis are collected from Shangjiang Honghua of Sichuan province, and identified as Magnoliaceae cortex Magnolia officinalis of fiscilalis Rehd.et Wils; magnolol (Dalian Meiren Biotechnology Co., Ltd., batch No. A0316AS, purity > 98%); honokiol reference (Dalian Meiren Biotechnology Co., Ltd., batch No. S0318AS, purity > 98%); polyethylene glycol 6000(PEG 6000); poloxamer 188 (F68).
Example 1 preparation method of solid dispersion of Magnolia officinalis alcohol extract of the present invention
1. Preparation of magnolia officinalis alcohol extract freeze-dried powder
Pulverizing cortex Magnolia officinalis decoction pieces to obtain coarse powder, weighing 1kg, extracting with 70% ethanol under reflux for 2 times, adding 8 times (v/w) of 70% ethanol each time, extracting for 1.5 hr, and filtering. Mixing the filtrates, concentrating under reduced pressure at 50 deg.C to recover solvent until no alcohol smell exists, freeze drying the extractive solution, and pulverizing to obtain Magnolia officinalis ethanol extract lyophilized powder (MOE).
2. Preparation of solid dispersion of magnolia officinalis alcohol extract
The solid dispersion of the magnolia officinalis alcohol extract is prepared by a solvent method. The specific method comprises the following steps:
weighing the Magnolia officinalis alcohol extract freeze-dried powder and a carrier according to the mass ratio of 1:5.4, wherein the carrier consists of polyethylene glycol 6000 and poloxamer 188 according to the mass ratio of 0.9: 1. Adding 10 times (v/w) of 90% ethanol into the lyophilized powder and vehicle, stirring with magnetic stirrer for 115min for dissolving, and mixing. Heating in 70 deg.C water bath, rotary evaporating to remove 90% ethanol, drying in vacuum drying oven at 45 deg.C for 24 hr, pulverizing, and sieving with 40 mesh sieve to obtain solid dispersion (MOE-SD) of cortex Magnolia officinalis ethanol extract.
The advantageous effects of the present invention are demonstrated by specific test examples below.
Experimental example 1 research on preparation of solid dispersion of alcoholic extract of Magnolia officinalis by different preparation methods
1. Test method
Different methods (solvent method, melting method, solvent-melting method and grinding method) are adopted to prepare the solid dispersion of the magnolia officinalis alcohol extract, and the optimal method for preparing the solid dispersion of the magnolia officinalis alcohol extract is researched.
A solvent method: the MOE prepared in example 1 and a carrier are weighed according to the mass ratio of 1:5, wherein the carrier is poloxamer 188. Adding 10 times (v/w) of 90% ethanol into the lyophilized powder and vehicle, stirring with magnetic stirrer for 115min for dissolving, and mixing. Heating in 70 deg.C water bath, rotary evaporating to remove 90% ethanol, drying in vacuum drying oven at 45 deg.C for 24 hr, pulverizing, and sieving with 40 mesh sieve to obtain solid dispersion (MOE-SD) of cortex Magnolia officinalis ethanol extract.
A melting method: the MOE prepared in example 1 and a carrier are weighed according to the mass ratio of 1:5, wherein the carrier is poloxamer 188. Putting the carrier in a crucible in water bath at 70 ℃ to reach a molten state, adding the weighed MOE, stirring for dissolving, uniformly mixing, quickly coating on the surface of a cooled steel plate, taking out after becoming brittle, putting in a vacuum drying oven, drying at 45 ℃ for 24h, drying, crushing, and sieving with a 40-mesh sieve to obtain the Magnolia officinalis alcohol extract solid dispersion (MOE-SD).
Solvent-melt method: the MOE prepared in example 1 and a carrier are weighed according to the mass ratio of 1:5, wherein the carrier is poloxamer 188. Putting the carrier in a crucible, heating in water bath at 70 ℃ to a molten state, adding 10 times (v/w) of MOE dissolved in 90% ethanol, stirring and mixing uniformly, removing the solvent in the solution by rotary evaporation, quickly coating on the surface of a cooled steel plate, taking out after becoming crisp, putting in a vacuum drying oven, drying at 45 ℃ for 24h, drying, crushing, and sieving with a 40-mesh sieve to obtain the magnolia officinalis alcohol extract solid dispersion (MOE-SD).
Grinding method: the MOE prepared in example 1 and a carrier are weighed according to the mass ratio of 1:5, wherein the carrier is poloxamer 188. And (3) placing the MOE and the carrier in a mortar, vigorously grinding, and sieving by a 40-mesh sieve to obtain the solid dispersion (MOE-SD) of the magnolia officinalis alcohol extract.
And (3) detecting the dissolution rate of the solid dispersion of the magnolia officinalis alcohol extract prepared by the 4 different methods. The specific detection method comprises the following steps: taking the solid dispersion (MOE-SD) of the magnolia officinalis alcohol extract containing 1g of MOE in each group, and directly putting the solid dispersion into a dissolving cup. According to the second method (Paddle method) of dissolution determination method [ pharmacopoeia of the people's republic of China 2015 edition of general rules of four departments 0931]900mL of artificial intestinal juice is used as a dissolution medium, and the rotating speed is 50 r.min-1The temperature of the dissolution liquid was (37. + -. 0.5) ℃ according to the method. Taking 5mL of solution after 5, 10, 15, 20, 30, 45, 60 and 120min respectively, adding the same volume of dissolution medium at the same temperature, taking out the solution, adding the same volume of methanol, filtering with 0.45 μm microporous membrane, and taking the subsequent filtrate as the sample solution. Taking the subsequent filtrate for sample chromatographic analysis. And calculating the accumulated total dissolution rate of the magnolol and the honokiol at different time points, and drawing a dissolution curve.
2. Test results
The test results are shown in FIG. 1.
As can be seen from fig. 1: the cumulative dissolution rate at 120min is solvent method > melting method > solvent-melting method > grinding method, so the solid dispersion of the magnolia officinalis alcohol extract prepared by the solvent method selected in the experiment effectively improves the total dissolution rate of magnolol and honokiol.
Experimental example 2 study on solid dispersion of Magnolia officinalis alcohol extract prepared by different types of carriers
1. Test method
The MOE prepared in example 1 is taken, the mass ratio of the MOE to the carrier is 1:5, and PEG6000, F68, hydroxypropyl methylcellulose (HPMC), polyvinylpyrrolidone (PVP K30) and PEG600: F68 (mass ratio is 1:1) are respectively selected as the carrier. When the solid dispersion of the magnolia officinalis alcohol extract is prepared, only the types of the carriers are changed, and the rest parameters and the preparation method are the same as the example 1.
Detecting the dissolution rate of the solid dispersion of the magnolia officinalis alcohol extract prepared by the different carriers. The specific detection method was the same as in test example 1.
2. Test results
The test results are shown in FIG. 2.
As can be seen from fig. 2: the cumulative dissolution at 120min was PEG 6000: f68 is more than PEG6000 and more than F68 is more than PVP K30 and more than HPMC, and the combined carrier can improve the total dissolution rate of magnolol and honokiol. In order to avoid the aging problem caused by a single carrier, PEG6000-F68 is combined with the carrier to prepare the solid dispersion of the magnolia officinalis alcohol extract in the research.
Experimental example 3 dissolution rates of solid dispersion of Magnolia officinalis alcohol extract in different dissolution media
1. Test method
The solid dispersion of the magnolia bark alcohol extract prepared in example 1 is taken. The dissolution rates of the compound in artificial gastric juice, artificial intestinal juice and pure water are respectively considered.
About 1g of MOE-SD was directly charged into a dissolution cup. According to the second method (Paddle method) of dissolution determination method [ pharmacopoeia of the people's republic of China 2015 edition of general rules of four departments 0931]900mL of artificial gastric juice, artificial intestinal juice and pure water are taken as dissolution media and the rotating speed is 50 r.min-1The temperature of the dissolution liquid was (37. + -. 0.5) ℃ according to the method. Taking 5mL of solution after 5, 10, 15, 20, 30, 45, 60 and 120min respectively, adding the same volume of dissolution medium at the same temperature, taking out the solution, adding the same volume of methanol, filtering with 0.45 μm microporous membrane, and taking the subsequent filtrate as the sample solution. Taking the subsequent filtrate for sample chromatographic analysis. And calculating the accumulated total dissolution rate of the magnolol and the honokiol at different time points, and drawing a dissolution curve.
2. Test results
The test results are shown in FIG. 3.
As can be seen from fig. 3: the cumulative dissolution rate at 120min is pure water > artificial gastric juice > artificial intestinal juice. The total dissolution rate of magnolol and honokiol in pure water and artificial gastric juice of the solid dispersion of the magnolia alcohol extract is obviously superior to that in artificial intestinal juice.
Experimental example 4 Effect of other parameters on solid Dispersion of Magnolia bark alcohol extract of the present invention
1. Test method
The influence of the carrier ratio (the mass ratio of the polyethylene glycol 6000 to the poloxamer 188), the drug loading ratio (the mass ratio of the magnolia officinalis alcohol extract freeze-dried powder to the carrier) and the stirring time on the total dissolution rate of magnolol and honokiol of the solid dispersion of the magnolia officinalis alcohol extract in 60min is researched. The preparation method of the solid dispersion of each group of the magnolia officinalis alcohol extracts only changes the carrier ratio, the drug loading ratio, the concentration of the solvent ethanol and the stirring time according to the table 1, and the other parameters and the preparation method are completely the same as the example 1.
2. Test results
The dissolution rate of the solid dispersion of the magnolia officinalis alcohol extract in each group is detected according to the method described in the experimental example 1. The dissolution rate results of the solid dispersion of the magnolia officinalis alcohol extract prepared by the preparation methods are shown in table 1.
TABLE 1 dissolution of solid dispersion of alcoholic extract of Magnolia officinalis of the present invention under different parameters
Figure BDA0002223545180000051
The test result shows that: when the solid dispersion of the magnolia officinalis alcohol extract is prepared, when the mass ratio of the polyethylene glycol 6000 to the poloxamer 188 is 0.9:1, the mass ratio of the magnolia officinalis alcohol extract freeze-dried powder to the carrier is 1:5.4, the stirring time is 115min, and the rest parameters and the preparation method are completely the same as those in example 1, the obtained solid dispersion of the magnolia officinalis alcohol extract has the largest dissolution rate, and the obtained solid dispersion of the magnolia officinalis alcohol extract is optimal.
In conclusion, the preparation method of the solid dispersion of the magnolia officinalis alcohol extract can prepare the solid dispersion of the magnolia officinalis alcohol extract with extremely high dissolution rate, is favorable for improving the total dissolution rate of magnolol and honokiol which are main effective ingredients of magnolia officinalis, improves the water solubility of the magnolia officinalis, improves the utilization rate of the magnolia officinalis, is convenient for further refining related preparations of the magnolia officinalis, and expands the clinical application.

Claims (7)

1. A preparation method of solid dispersion of magnolia officinalis alcohol extract is characterized in that: it comprises the following steps:
dissolving Magnolia officinalis ethanol extract lyophilized powder and carrier in ethanol solution, rotary evaporating to remove ethanol solution, drying, and pulverizing;
the carrier consists of polyethylene glycol and poloxamer;
the polyethylene glycol is polyethylene glycol 6000; the poloxamer is poloxamer 188;
the mass ratio of the magnolia officinalis alcohol extract freeze-dried powder to the carrier is 1: 5.4; the mass ratio of the polyethylene glycol to the poloxamer in the carrier is 0.9: 1;
and stirring while dissolving in the ethanol solution, wherein the stirring time is 115 min.
2. The method of claim 1, wherein: the ethanol solution is 80-95% ethanol solution; and/or the volume of the ethanol solution is 8-12 times (v/w) of the total mass of the magnolia officinalis alcohol extract freeze-dried powder and the carrier.
3. The method of claim 2, wherein: the ethanol solution is 90% ethanol solution; and/or the volume of the ethanol solution is 10 times (v/w) of the total mass of the magnolia officinalis alcohol extract freeze-dried powder and the carrier.
4. The method of claim 1, wherein: the rotary evaporation condition is 70 ℃ water bath heating; and/or the drying is drying for 24 hours in a vacuum drying oven at 45 ℃; and/or, sieving the crushed materials by a 40-mesh sieve.
5. The method of claim 1, wherein: the preparation method of the magnolia officinalis alcohol extract freeze-dried powder comprises the following steps:
taking mangnolia officinalis decoction pieces, crushing, carrying out hot reflux extraction on the mangnolia officinalis decoction pieces for 1-3 times by using 70-80% ethanol, filtering, combining filtrates, concentrating under reduced pressure, freeze-drying, and crushing to obtain the mangnolia officinalis decoction pieces; adding 6-10 times (v/w) of ethanol into the reflux extraction every time; the reflux extraction is carried out for 1-3 h each time.
6. The method of claim 5, wherein: the preparation method of the magnolia officinalis alcohol extract freeze-dried powder comprises the following steps:
pulverizing cortex Magnolia officinalis decoction pieces, extracting with 70% ethanol under reflux for 2 times, filtering, mixing filtrates, concentrating under reduced pressure, freeze drying, and pulverizing; adding 8 times (v/w) of ethanol into the reflux extraction every time; the reflux extraction is carried out for 1.5h each time.
7. The method of claim 5, wherein: the reduced pressure concentration is carried out at 50 ℃, and the solvent is recovered by reduced pressure concentration until no alcohol smell exists.
CN201910943398.5A 2019-09-30 2019-09-30 Preparation method of solid dispersion of magnolia officinalis alcohol extract Active CN110585137B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910943398.5A CN110585137B (en) 2019-09-30 2019-09-30 Preparation method of solid dispersion of magnolia officinalis alcohol extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910943398.5A CN110585137B (en) 2019-09-30 2019-09-30 Preparation method of solid dispersion of magnolia officinalis alcohol extract

Publications (2)

Publication Number Publication Date
CN110585137A CN110585137A (en) 2019-12-20
CN110585137B true CN110585137B (en) 2021-10-19

Family

ID=68865330

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910943398.5A Active CN110585137B (en) 2019-09-30 2019-09-30 Preparation method of solid dispersion of magnolia officinalis alcohol extract

Country Status (1)

Country Link
CN (1) CN110585137B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012242A (en) * 2015-07-21 2015-11-04 南京中医药大学 Solid dispersion prepared from magnolol, honokiol or mixture of magnolol and honokiol and preparation method of solid dispersion by hot-melt extrusion

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012242A (en) * 2015-07-21 2015-11-04 南京中医药大学 Solid dispersion prepared from magnolol, honokiol or mixture of magnolol and honokiol and preparation method of solid dispersion by hot-melt extrusion

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
厚朴总酚固体分散体不同制备方法的比较研究;李杰,等;《中国中药杂志》;20151130;第40卷(第22期);4400-4405 *
厚朴酚-交联羧甲基纤维素钠固体分散体的制备及体外溶出研究;唐岚,等;《中国中药杂志》;20160229;第41卷(第3期);433-437 *

Also Published As

Publication number Publication date
CN110585137A (en) 2019-12-20

Similar Documents

Publication Publication Date Title
KR101488208B1 (en) Burdock Fruit Extract Containing Arctigenin at High Content and Process for Producing Same
CN106173024A (en) A kind of production method of Cyclocarya paliurus Iljinskaja green tea instant tea
CN109528803B (en) Preparation method of radix pseudostellariae extract, radix pseudostellariae extract prepared by preparation method and detection method
CN101720834A (en) Pu'er tea health-care food and preparation method thereof
CN110637961A (en) A solid beverage prepared from black ginseng, and its preparation method
CN110558470A (en) A solid beverage prepared from sun-dried Ginseng radix and radix Ginseng Indici, and its preparation method
CN110447889A (en) A kind of preparation method of Ganodenna Lucidum P.E
KR101189605B1 (en) White pleuropterus multiflorus and phlomis umbrosa extract for promoting insulin-like growth factor secretion and bone framework growth, and method for producing the same
US6447815B1 (en) Heated alcohol extraction of herbs
CN101623313A (en) Method for preparing traditional Chinese medicine preparation for tonifying blood
CN110585137B (en) Preparation method of solid dispersion of magnolia officinalis alcohol extract
NZ543995A (en) Processes for making caralluma extracts and uses
CN1814170A (en) Medicinal drop pills for treating cardiovascular disease and preparing method
AP25A (en) Stabilisation of tea in cold water.
CN101380049B (en) Black tea extract rich in statins and preparation technique and use thereof
CN108619374B (en) Ginseng and fritillary bulb composition as well as preparation method and application thereof
CN108888748A (en) A kind of preparation process of banxia xiexin decoction solid pharmaceutical preparation
KR100972941B1 (en) Composition comprising an extract of black ginseng for preventing or treating hepatoma
CN112603934A (en) Chinese angelica and ligusticum wallichii composition and preparation method thereof
CN107041903B (en) Integrated new method for processing and concocting radix Polygoni Multiflori Preparata in producing area
CN104922187A (en) Oral honeysuckle solution and preparation method thereof
CN115337333B (en) Preparation method of classical formula concha haliotidis powder preparation
CN114209723B (en) Composition for assisting in reducing blood fat, product containing composition and application
CN116831990A (en) Loquat lung-heat-clearing drink granule and preparation method thereof
CN111013185B (en) Method for enriching characteristic phenols in alligator pepper

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant